{"id":2,"date":"2017-03-31T11:50:42","date_gmt":"2017-03-31T15:50:42","guid":{"rendered":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/?page_id=2"},"modified":"2017-04-11T13:24:21","modified_gmt":"2017-04-11T17:24:21","slug":"home","status":"publish","type":"page","link":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/","title":{"rendered":"Home"},"content":{"rendered":"<div id=\"pl-2\"  class=\"panel-layout\" ><div id=\"pg-2-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-2-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-2-0-0-0\" class=\"so-panel widget widget_widget_sp_image widget_sp_image panel-first-child panel-last-child\" data-index=\"0\" ><img loading=\"lazy\" decoding=\"async\" width=\"1170\" height=\"456\" alt=\"Mansoor Sarfarazi, Ph.D., in his Molecular Ophthalmic Genetics Laboratory\" class=\"attachment-full\" style=\"max-width: 100%;\" srcset=\"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-content\/uploads\/sites\/130\/2017\/04\/Sarfarazi33.jpg 1170w, https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-content\/uploads\/sites\/130\/2017\/04\/Sarfarazi33-300x117.jpg 300w, https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-content\/uploads\/sites\/130\/2017\/04\/Sarfarazi33-768x299.jpg 768w, https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-content\/uploads\/sites\/130\/2017\/04\/Sarfarazi33-1024x399.jpg 1024w\" sizes=\"(max-width: 1170px) 100vw, 1170px\" src=\"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-content\/uploads\/sites\/130\/2017\/04\/Sarfarazi33.jpg\" \/><\/div><\/div><\/div><div id=\"pg-2-1\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-2-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-2-1-0-0\" class=\"so-panel widget widget_black-studio-tinymce widget_black_studio_tinymce panel-first-child panel-last-child\" data-index=\"1\" ><div class=\"textwidget\"><p><strong>Dr. Mansoor Sarfarazi <\/strong>and the Molecular Ophthalmic Genetics Laboratory is studying the genetics of glaucoma. Specifically, research is being done on adult-onset primary open-angle glaucoma caused by mutations in\u00a0<span class=\"style7\"><em><strong>Optineurin<\/strong><\/em><\/span> and<span class=\"style7\"> <em><strong>WDR36<\/strong><\/em><\/span> genes.<\/p>\n<p>Primary open-angle glaucoma (POAG) affects 33 million individuals worldwide and is a leading cause of blindness. In a study of 54 families with autosomal dominantly inherited adult-onset POAG, we identified the causative gene on chromosome 10p14 and designated it <em><strong>OPTN<\/strong><\/em> or <em><strong>Optineurin<\/strong><\/em> (for \"<span class=\"style5\"><strong>Opti<\/strong><\/span>c <span class=\"style5\"><strong>Neur<\/strong><\/span>opathy <span class=\"style5\"><strong>In<\/strong><\/span>ducing protein\"). Sequence alterations in <em>OPTN<\/em> were found in 16.7% of families with hereditary POAG, including individuals with normal intraocular pressure. The <em>OPTN<\/em> gene codes for a conserved 66-kilodalton protein of unknown function that has been implicated in the tumor necrosis factor-alpha signaling pathway and that interacts with diverse proteins including Huntingtin, Ras-associated protein RAB8, and transcription factor IIIA. Optineurin is expressed in trabecular meshwork, non-pigmented ciliary epithelium, retina, and brain, and we speculate that it plays a neuroprotective role.<\/p>\n<p>We have also mapped three autosomal recessive loci for Primary Congenital Glaucoma (<em>GLC3A<\/em>, <em>GLC3B<\/em>, <em>GLC3C<\/em>) and further identified the <span class=\"style6\"><em><strong>CYP1B1<\/strong><\/em><\/span> (Cytochrome P450 1B1) as the causing gene at the <em>GLC3A<\/em> locus.<\/p>\n<\/div><\/div><\/div><div id=\"pgc-2-1-1\"  class=\"panel-grid-cell\" ><div id=\"panel-2-1-1-0\" class=\"so-panel widget widget_black-studio-tinymce widget_black_studio_tinymce panel-first-child panel-last-child\" data-index=\"2\" ><div class=\"panel-widget-style panel-widget-style-for-2-1-1-0\" ><div class=\"textwidget\"><h2>Contact<\/h2>\n<p><strong>Mansoor Sarfarazi, Ph.D.<\/strong><br \/>\nMolecular Ophthalmic Genetics Laboratory<br \/>\nUConn Health<br \/>\n263 Farmington Avenue<br \/>\nFarmington, CT 06030-1110<\/p>\n<p>Office: 860-679-3629<br \/>\nLab: 860-679-3923<br \/>\nFax: 860-679-7524<br \/>\nEmail: <a href=\"mailto:mansoor@uchc.edu\">mansoor@uchc.edu<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><div id=\"pg-2-2\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-2-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-2-2-0-0\" class=\"so-panel widget widget_black-studio-tinymce widget_black_studio_tinymce panel-first-child panel-last-child\" data-index=\"3\" ><div class=\"textwidget\"><p><a class=\"btn btn-success\" style=\"width: 100%\" href=\"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/publications\/\">Publications<\/a><\/p>\n<\/div><\/div><\/div><div id=\"pgc-2-2-1\"  class=\"panel-grid-cell\" ><div id=\"panel-2-2-1-0\" class=\"so-panel widget widget_black-studio-tinymce widget_black_studio_tinymce panel-first-child panel-last-child\" data-index=\"4\" ><div class=\"textwidget\"><p><a class=\"btn btn-success\" style=\"width: 100%\" href=\"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/online-resources\/\">Online Resources<\/a><\/p>\n<\/div><\/div><\/div><div id=\"pgc-2-2-2\"  class=\"panel-grid-cell panel-grid-cell-mobile-last\" ><div id=\"panel-2-2-2-0\" class=\"so-panel widget widget_black-studio-tinymce widget_black_studio_tinymce panel-first-child panel-last-child\" data-index=\"5\" ><div class=\"textwidget\"><p><a class=\"btn btn-success\" style=\"width: 100%\" href=\"http:\/\/facultydirectory.uchc.edu\/profile?profileId=Sarfarazi-Mansoor\">Safarazi Faculty Page<\/a><\/p>\n<\/div><\/div><\/div><div id=\"pgc-2-2-3\"  class=\"panel-grid-cell panel-grid-cell-empty\" ><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Dr. Mansoor Sarfarazi and the Molecular Ophthalmic Genetics Laboratory is studying the genetics of glaucoma. Specifically, research is being done on adult-onset primary open-angle glaucoma caused by mutations in\u00a0Optineurin and WDR36 genes.Primary open-angle glaucoma (POAG) affects 33 million individuals worldwide and is a leading cause of blindness. In a study of 54 families with autosomal [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"page-blank.php","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-12 01:25:21","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-json\/wp\/v2\/pages\/2"}],"collection":[{"href":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":7,"href":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"predecessor-version":[{"id":24,"href":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-json\/wp\/v2\/pages\/2\/revisions\/24"}],"wp:attachment":[{"href":"https:\/\/health.uconn.edu\/molecular-ophthalmic-genetics-lab\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}